NMRAL2P and head and neck neoplasm: To reverse-verify the function of NMRAL2P in head and neck tumor cells, we transferred NMRAL2P-ASO into TU177 and AMC-HN-8 cells, respectively, and the relative expression of NMRAL2P in TU177 and AMC-HN-8 was knocked down by more than 40% (Figs. 3A, 3B).